Curated News
By: NewsRamp Editorial Staff
August 26, 2026
20Slash20's Eye Drink to be Showcased at Moody Capital Conference
TLDR
- 20Slash20 CEO presents at Moody Capital's 2026 conference, gaining investor exposure and potential funding for The Eye Drink.
- 20Slash20's The Eye Drink uses science-backed ingredients to support eye health, targeting screen-heavy lifestyles with a ready-to-drink format.
- The Eye Drink offers a convenient way to protect eyes from screen strain, improving daily wellness in a digital age.
- 20Slash20 introduces The Eye Drink, the first functional beverage designed specifically for those glued to screens.
Impact - Why it Matters
This news matters because it highlights the growing intersection of health and technology, as screen usage continues to rise globally. 20Slash20's participation in the Moody Capital Solutions 2026 conference signals investor interest in functional beverages targeting eye health, a niche yet expanding market. For consumers, The Eye Drink offers a convenient solution to combat digital eye strain, which is becoming a common health concern. For investors, the conference presentation provides an opportunity to evaluate a disruptive product in the life sciences space. The company's proactive engagement with investors could pave the way for future growth and market penetration, potentially influencing the functional beverage industry and how we approach eye care in a screen-centric world.
Summary
20Slash20 Inc., the creator of The Eye Drink, is set to participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference in New York City on Sept. 9–10, 2026. CEO Dr. Roger Wu will deliver an investor presentation at 9:35 a.m. ET on Sept. 9 at The Westin New York Grand Central, and will also engage in one-on-one meetings with investors. The conference brings together growth companies, investors, and industry professionals, offering 20Slash20 a platform to showcase its innovative product to a targeted audience.
The Eye Drink is touted as the world's first ready-to-drink functional beverage formulated with science-backed ingredients to support eye health, particularly for those who spend prolonged periods on screens. In today's digital age, where screen time is pervasive, this product addresses a growing concern about eye strain and related issues. The presentation at the conference will highlight the company's vision and the potential of its product in the functional beverage market.
InvestorWire (IW), a specialized communications platform, is disseminating this news. IW is part of the Dynamic Brand Portfolio @ IBN, which offers a range of services including press release syndication, editorial distribution to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions. For the full press release, visit https://ibn.fm/tm2lT. InvestorWire is dedicated to providing broad reach and brand awareness for its clients in the investment community.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, 20Slash20's Eye Drink to be Showcased at Moody Capital Conference
